ALT
Price:
$2.61
Market Cap:
$230.35M
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for obesity and various liver diseases. Its primary investigational drug, pemvidutide (proposed INN, previously known as ALT-801), operates as a GLP-1/glucagon dual receptor agonist. This compound is currently undergoing Phase 1b clinical trials, exploring its efficacy in treating both obesity and non-alcoholic steatohepatitis (NASH). Additionally, Altimmune is advancing HepTcell, an immunotherapeutic candidate, through Phase 2 clinical trials. This therapy is designed for individuals suffering from chronic hepatitis B virus infection. The enterprise, initially named Vaxin Inc., officially adopted ...[Read more]
Industry
Biotechnology
IPO Date
2017-05-26
Stock Exchange
NASDAQ
Ticker
ALT
Dividends are a key part of long-term returns for investors, and Altimmune, Inc. (ALT) has a track record worth reviewing. Looking at dividend history for ALT gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2017-02-06
Dividend Yield
0%
Annual Dividend
$291.00
P/E Ratio
-2.84
Payout Ratio
0
Dividend per Share
$0
EPS
-0.92
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2017-02-06 | $291 | $873 | 2016-11-17 | |
| 2017-01-20 | $291.0033 | $873.01 | 2017-02-03 |
The table below shows Altimmune, Inc. (ALT) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Altimmune, Inc. (ALT) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Altimmune, Inc. (ALT) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is ALT’s dividend yield?
What is the difference between regular and special dividends?
Has ALT increased its dividends over time?
Why might dividend history data be delayed?
How often does ALT pay dividends?
What factors impact ALT's dividend payments?
Can dividends change over time?
What is ALT’s next dividend date?